Well.. Q1 result was really good and usually Q2 is better in terms of clinical trials sales contracts but the last quarter was not that good almost on par with previous years Q2 result. If there's an indication that the current quarter is seeing exponential growth like Q1, we'll probably do ok but it's anyone's guess.
CGS Price at posting:
$1.88 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)